Oct 03, 2026
Pfizer Inc. (NYSE:PFE) on Thursday presented detailed Phase 2 results for tilrekimig (PF-07275315) in adults with moderate-to-severe atopic dermatitis. The ongoing trial met its primary endpoint, showing a statistically significant…
Novo Nordisk A/S (NYSE:NVO) on Monday outlined a broad strategic roadmap targeting sustained global expansion during its Capital Markets Day 2026 presentation. The company reported…
United Airlines Holdings (NASDAQ:UAL) has outperformed the market over the past 5 years by 7.4% on an annualized basis producing an average annual return of…
Ripple CEO Brad Garlinghouse criticized Senate Democrats after the CLARITY Act failed to advance Tuesday, but said crypto regulation in the U.S. could now shift…